Kidney Disease News and Research

RSS

Study challenges conventional thinking about the onset of Type 2 diabetes

A study from The University of Texas at San Antonio Health Science Center indicates that changes in the body that lead to Type 2 diabetes occur long before current diagnostic thresholds for prediabetes are met.

11 Sep 2025

Chronic illness death rates decline but pace of progress slows

Death rates from chronic diseases have fallen in four out of five countries around the world in the last decade - but progress has slowed, suggests an analysis led by researchers at Imperial College London and published in The Lancet.

10 Sep 2025

Using AI models to improve prediction of CKD's progression to end-stage renal disease

Chronic kidney disease (CKD) is a complex condition marked by a gradual decline in kidney function, which can ultimately progress to end-stage renal disease (ESRD).

9 Sep 2025

AI voice agents helped improve accuracy of blood pressure measurements in older adults

Artificial intelligence (AI) voice agents helped older adults with high blood pressure to accurately report their blood pressure readings and improved blood pressure management, according to preliminary research presented at the American Heart Association's Hypertension Scientific Sessions 2025.

8 Sep 2025

New class of antihypertensive medications may have both kidney- and cardio-protective benefits

Adding the novel medication baxdrostat to standard care may help manage high blood pressure and delay the progression of kidney disease in people with chronic kidney disease and uncontrolled high blood pressure , according to preliminary research presented at the American Heart Association's Hypertension Scientific Sessions 2025.

8 Sep 2025

Childhood blood pressure predicts cardiovascular mortality risk in adulthood

Blood pressure matters at all ages. Children with higher blood pressure at age 7 may be at an increased risk of dying of cardiovascular disease by their mid-50s, according to preliminary research presented at the American Heart Association's Hypertension Scientific Sessions 2025.

8 Sep 2025

WHO expands essential medicines lists with new cancer and diabetes treatments

Today, the World Health Organization (WHO) has released updated editions of its Model Lists of Essential Medicines (EML) and Essential Medicines for Children (EMLc), adding new treatments for various types of cancer and for diabetes with associated comorbidities such as obesity.

5 Sep 2025

Study shows sharp increase in kidney disease deaths linked to high blood pressure

The death rate from hypertensive kidney disease (high blood pressure-related kidney disease) increased by 48% in the U.S. over the past 25 years, with continued differences across demographic groups, according to preliminary research presented at the American Heart Association's Hypertension Scientific Sessions 2025.

5 Sep 2025

Salt substitute use remains low among Americans with high blood pressure

Few people with high blood pressure were using salt substitutes, even though they are a simple and effective way to lower sodium intake and manage blood pressure, according to preliminary research presented at the American Heart Association's Hypertension Scientific Sessions 2025.

4 Sep 2025

Estrogen supports kidney regeneration and protects women from chronic disease

A new study in mice provides insights into why females in their reproductive years appear to be relatively protected from chronic kidney disease, a leading public health concern.

4 Sep 2025

Changes at NIH give political appointees greater power to fund or block research

The Trump administration has given notice that political appointees, rather than scientists, will ultimately decide who gets grant money from the world’s largest biomedical research funder — the federal government's National Institutes of Health.

3 Sep 2025

Aptamer signs therapeutic development agreement with Invizius

Aptamer Group plc, the developer of next-generation synthetic binders for the life sciences industry, is pleased to announce that it has signed a new therapeutic development agreement with Invizius, a clinical-stage biotechnology company focused on second-generation complement system therapies for inflammatory, fibrotic, and autoimmune diseases.

From Aptamer Group 2 Sep 2025

Baxdrostat offers hope for millions with difficult-to-control high blood pressure

A new treatment has been shown to significantly lower blood pressure in people whose levels stay dangerously high, despite taking several existing medicines, according to the results of a Phase III clinical trial led by a UCL Professor.

1 Sep 2025

Adding aspirin raises cardiovascular events in high-risk CCS patients on anticoagulants

Adding aspirin increased the risk of cardiovascular events, death and major bleeding in high-risk patients with chronic coronary syndrome (CCS) who had prior stenting and were receiving long-term chronic oral anticoagulation (OAC), according to late-breaking research presented in a Hot Line session today at ESC Congress 2025 and simultaneously published in New England Journal of Medicine.

1 Sep 2025

Lubiprostone shows promise in slowing kidney disease progression

Chronic kidney disease (CKD) is a major health issue worldwide. Many patients end up requiring regular dialysis to avoid kidney failure and stay alive.

1 Sep 2025

Constipation drug found to slow renal function decline in CKD patients

Chronic kidney disease (CKD) is a major health issue worldwide. Many patients end up requiring regular dialysis to avoid kidney failure and stay alive.

29 Aug 2025

Glycosylation emerges as a key player in kidney disease progression

Kidney diseases affect nearly 700 million people worldwide and are a growing cause of mortality and health care costs.

29 Aug 2025

PREVENT equations provide more accurate risk estimates and support personalized hypertension care

Using the Predicting Risk of cardiovascular disease EVENTs (PREVENT™) equations provides more accurate risk estimates and supports personalized treatment for adults with high blood pressure or hypertension, according to a new scientific statement published today in the American Heart Association's peer-reviewed journals Circulation and Hypertension, and in JACC, the flagship journal of the American College of Cardiology.

28 Aug 2025

Evidence-based calculator to guide hypertension treatment choices

A first-of-its-kind Blood Pressure Treatment Efficacy Calculator built on data from nearly 500 randomized clinical trials in over 100,000 people allows doctors to see by how much different medications are likely to lower blood pressure.

28 Aug 2025

Small peptide produced by gut bacteria identified as key factor in kidney fibrosis

A molecule made by bacteria in the gut can hitch a ride to the kidneys, where it sets off a chain reaction of inflammation, scarring and fibrosis - a serious complication of diabetes and a leading cause of kidney failure - according to a new study from researchers at the University of Illinois Urbana-Champaign and Mie University in Japan.

25 Aug 2025

Kidney Disease News and Research

Study challenges conventional thinking about the onset of Type 2 diabetes

Chronic illness death rates decline but pace of progress slows

Using AI models to improve prediction of CKD's progression to end-stage renal disease

AI voice agents helped improve accuracy of blood pressure measurements in older adults

New class of antihypertensive medications may have both kidney- and cardio-protective benefits

Childhood blood pressure predicts cardiovascular mortality risk in adulthood

WHO expands essential medicines lists with new cancer and diabetes treatments

Study shows sharp increase in kidney disease deaths linked to high blood pressure

Salt substitute use remains low among Americans with high blood pressure

Estrogen supports kidney regeneration and protects women from chronic disease

Changes at NIH give political appointees greater power to fund or block research

Aptamer signs therapeutic development agreement with Invizius

Baxdrostat offers hope for millions with difficult-to-control high blood pressure

Adding aspirin raises cardiovascular events in high-risk CCS patients on anticoagulants

Lubiprostone shows promise in slowing kidney disease progression

Constipation drug found to slow renal function decline in CKD patients

Glycosylation emerges as a key player in kidney disease progression

PREVENT equations provide more accurate risk estimates and support personalized hypertension care

Evidence-based calculator to guide hypertension treatment choices

Small peptide produced by gut bacteria identified as key factor in kidney fibrosis

Free guide - Everything about renal proximal tubule cells eBook

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News